Editorial

Ongoing Studies of the Bladder Tumor Study Group: An Overview

• N. Aydın Mungan
• İlker Tınay

Review

Is radical cystectomy the gold standard?

• Binhan Kağan Aktaş
• Ali Memiş

Bladder cancer epidemiology in the world and in Tukey

• Sultan Eser
• Raziye Özdemir

Robotic surgery in radical cystectomy

• Yakup Kordan
• Burhan Coşkun

Genetik alteration in bladder carcinoma

• Hakan Akça
• Onur Tokgün

Geometry of cancer and fractals in bladder cancer

• Fehmi Narter
• Osman Köse

Positron Emission Tomography/Computed Tomography in Bladder Carcinoma

• Recep Bekiş
• Emine Acar
• Uğur Mungan

The approaches in uncommon malignant tumours of the bladder

• Hayrettin Şahin

The Relationship between Bladder Cancer and Epigenetic Alterations

• Ata Özen
• Ali Ülgen
• Cavit Can

Second-TUR

• Ali Feyzullah Şahin
• Rauf Taner Divrik

BCG suşlarının tedavi edici etkinlik farkı var mı?

• Hayrettin Şahin

The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View

• Barış Kuzgunbay
• Yıldırım Bayazıt

What is the current status of bladder tumor markers?

• İbrahim Dönmez
• N. Aydın Mungan

İdame BCG kime uygulanmalı nasıl uygulanmalı?

• Çetin Volkan Öztekin
• Veli Erşahin

Is intravesical BCG treatment necessary and/or sufficient?

• Sinan Ekici
• Polat Türker

The Role of Radiology in Perivesical Invasion of Muscle-Invasive Bladder Cancer

• İbrahim İlker Öz
• Aydın Mungan

BCG komplikasyonları ve başa çıkma

• Uğur Yücetaş
• Gökhan Toktaş

Radical Cystectomy in Elderly Patients: Predicting Complications and Mortality, Technical Aspects and Postoperative Care

• Uğur Kuyumcuoğlu
• Kaan Özdedeli

Nutritional evaluation of patients who are candidate for radical cystectomy

• Osman Köse
• Öztuğ Adsan

Flüoresan sistoskopi ve tur'un geleceği var mı?

• Gökhan Özer

Which Patients Should Undergo Immediate or Deferred Cystectomy in Non-Muscle Invazive Bladder Cancer? Evaluation of...

• Şenol Tonyalı
• Mustafa Sertaç Yazıcı

Experimental Bladder Cancer Models for Animals

• Murat Koşan
• Aydın Mungan

Should all patients with non-muscle invaziv bladder tumor receive postoperative early single dose intravesical chemotherapy?

• Sümer Baltacı
• Ömer Gülpınar

Limited-standard-extended lymphadenectomy in bladder cancer

• Hayrettin Şahin

Bipolar veya plazmakinetik enerji ile yapılan TUR-M operasyonlarının klasik metottan farkı var mı?

• Binhan Kağan Aktaş
• Mehmet Murat Baykam

Synchronous and Metachronous Secondary Tumors of Bladder Cancer Patients

• Ayhan Dirim
• Hakan Özkardeş
• Eray Hasırcı

Approach to the complications of intravesical therapy in bladder cancer

• Turgay Gülecen
• Cüneyd Özkürkçügil

Dev Ta Tümörde TUR nasıl Yapılmalıdır?

• Taylan Oksay

Bladder cancer and genetics

• Ata Özen
• Cavit Can

TUR'a bağlı mesane perforasyonu: tedavi ve izlem

• Kürsad Zengin
• Sinan Başay

Screening for Bladder Cancer: Reliability and Limitations

• Kamil Fehmi Narter
• Cahit Şahin

Importance of mycobacteria in treatment of bladder tumor

• Esra Büber
• Selçuk Keskin
• N. Leyla Açan

Parsiyel sistektomiyi unuttuk mu?

• C. Serkan Gökkaya
• Ali Memiş

Nursing care following radical cystectomy and urinary diversion

• Cemile Ulubay Akkaya

Kadın sistektomisinde histerektomi ve vajinal kaf çıkarma ayrılmaz bir parça mıdır? Neden?

• Süleyman Bulut

Supportive treatment for patient receiving gemsitabine-cisplatine and suggestions for nursing

• Yeter Kırdal

Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?

• Polat Türker
• Sinan Ekici

History of Urologic Oncology in Turkey: Bladder Cancers

• Yaşar Bedük

Diagnosis and management of the strictures after prostatectomy

• Murat Akand
• Serdar Göktaş

Genişletilmiş lenfadenektomi standart bir tedavi olmalı mı?

• Ömer Gökhan Doluoğlu
• Mehmet Karabakan

Experimental animal models for bladder cancer

• Şevket Tolga Tombul
• Talha Müezzinoğlu

Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup

• Yılören Tanıdır
• İlker Tınay

Açık, laparoskopik ve robotik sistektomi: avantaj ve dezavantajları

• Bülent Altunoluk

Is TUR-B operations can be done in the office conditions by using local anesthesia

• Tansu Değirmenci
• Bülent Günlüsoy

Radiological methods that aid in the diagnosis of bladder cancer

• Fatih Kantarcı
• Deniz Çebi Olgun
• Atilla Süleyman Dikici

Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)

• Cavit Can

Quality of Life after Radical Cystectomy and Diversion

• Gökhan Toktaş
• Emre Karabay

Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer

• Elif Atağ
• Aziz Karaoğlu
• Ömer Küçük

Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer

• Aziz Karaoğlu
• Utku Oflazoğlu
• Necla Demir

Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer

• Erem Bilensoy
• Nazlı Erdoğar
• Aydın N. Mungan

Targeted Therapies in Metastatic Bladder Cancer: Has It Been Approved as a Treatment Option Nowadays?

• Nil Molinas Mandel

How Can One Define the Surgical Quality of Radical Cystectomy?

• Mesut Altan
• Burhan Özdemir
• Burak Çıtamak
• Bülent Akdoğan
• Haluk Özen

Surgical Approaches in Patients with Metastatic Bladder Cancer: Metastasectomy and Palliative Cystectomy

• Utku Lokman
• Özgür Uğurlu

Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome

• Polat Türker

Transurethral Resection of Bladder Cancer (TUR-B) for Non-Muscle Invasive Bladder Cancer: How to Reach Excellence?

• Mehmet İlker Gökçe
• Yaşar Bedük

Relationship Between Human Papilloma Virus and Bladder Cancer

• Osman İnci
• Ebru Taştekin
• Hakan Akdere

Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?

• Ali Furkan Batur
• Sinan Sözen

The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?

• Polat Türker
• Levent Türkeri

Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery

• Mehmet Kaynar
• Serdar Göktaş

Does Urinary Cytology Find the Value in the Detection and Follow-up of Urinary Bladder Cancer?

• Kutsal Yörükoğlu

Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis of Patients with Non-Muscle Invasive Bladder Cancer: A Review Based on Meta-Analysis

• Emre Tüzel

Bladder Perforation During TUR of Non Muscle Invasive Bladder Tumours: Early and Late Management

• Deniz Arslan

Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature

• Cem Yücel
• Mehmet Zeynel Keskin

Tumor Like Lesions of the Bladder

• Şeyda Erdoğan
• Emine Kılıç Bağır

Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches

• Zafer Küçükodacı
• Kutsal Yörükoğlu

Uropathology

Mesanenin “Inverted” (Devrik) Papillomu

• Nalan Neşe

Recently described and new variants of urothelial carcinoma of the urinary bladder, overview of the variants. Do we need a new classification?

• Kemal Behzatoğlu

Quality Of Life

Male lower urinary tract symptoms: An update – overactive bladder or not ?

• Tufan Tarcan
• İlker Tınay

The impact of control cystoscopies' on quality of life in the surveillance of bladder tumor

• İlker Çelen

Bph

Urodynamic studies in Benign Prostate Hyperplasia: whom and when?

• Umut Gönülalan
• Murat Koşan

Antimuscarinics in the treatment of overactive bladder: does one fit all? Can treatment be individualized?

• Ceyhun Özyurt